Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.69% |
| 2 | Technology | 13.64% |
| 3 | Financials | 12.49% |
| 4 | Miscellaneous | 10.87% |
| 5 | Consumer Discretionary | 10.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Accuray
ARAY
$31.3M
| $4.29M | 0.01% |
1,257,268
+570,087
| +83% | +$2.31M |
|
1677
Live Oak Bancshares
LOB
$1.85B
| $4.28M | 0.01% |
+289,239
| New | +$5.58M |
|
|
APTI
1678
DELISTED
Apptio, Inc. Class A Common Stock
APTI
| $4.28M | 0.01% |
112,702
-465,274
| -81% | -$15.7M |
|
|
ELME
1679
Elme Communities
ELME
$148M
| $4.28M | 0.01% |
+185,896
| New | +$5.11M |
|
|
SPTN
1680
DELISTED
SpartanNash
SPTN
| $4.27M | 0.01% |
248,398
-20,764
| -8% | -$378K |
|
|
STNL
1681
DELISTED
Sentinel Energy Services Inc. Class A Common Stock
STNL
| $4.26M | 0.01% |
+424,710
| New | +$4.26M |
|
1682
Sonoco
SON
$5.61B
| $4.25M | 0.01% |
80,069
-24,766
| -24% | -$1.36M |
|
1683
Central Garden & Pet Co Class A
CENTA
$2.36B
| $4.24M | 0.01% |
169,514
-211,274
| -55% | -$5.06M |
|
1684
Terreno Realty
TRNO
$7.31B
| $4.23M | 0.01% |
120,158
-245,316
| -67% | -$9.16M |
|
1685
iShares MSCI South Korea ETF
EWY
$28.3B
| $4.22M | 0.01% |
71,700
-299,314
| -81% | -$18.1M |
|
1686
CALL
Opko Health
OPK
$1.12B
| $4.21M | 0.01% |
1,400,000
-650,000
| -32% | -$2.2M |
|
1687
Karyopharm Therapeutics
KPTI
$44.2M
| $4.19M | 0.01% |
29,840
-25,889
| -46% | -$4.37M |
|
1688
Verastem
VSTM
$668M
| $4.19M | 0.01% |
104,003
+99,803
| +2,376% | +$6.09M |
|
1689
CALL
Yum China
YUMC
$15.3B
| $4.19M | 0.01% |
125,000
| – | – |
|
|
ACRE
1690
Ares Commercial Real Estate
ACRE
$257M
| $4.19M | 0.01% |
321,269
+123,156
| +62% | +$1.72M |
|
|
LTC
1691
LTC Properties
LTC
$2.19B
| $4.19M | 0.01% |
100,461
+72,574
| +260% | +$3.18M |
|
1692
Liquidia Corp
LQDA
$6.25B
| $4.19M | 0.01% |
193,277
+92,399
| +92% | +$2.16M |
|
1693
Prestige Consumer Healthcare
PBH
$2.43B
| $4.17M | 0.01% |
135,193
+108,686
| +410% | +$3.97M |
|
1694
Tactile Systems Technology
TCMD
$524M
| $4.17M | 0.01% |
91,603
-31,986
| -26% | -$1.85M |
|
1695
SS&C Technologies
SSNC
$19.6B
| $4.17M | 0.01% |
+92,488
| New | +$4.49M |
|
|
SUM
1696
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $4.16M | 0.01% |
341,099
-756,652
| -69% | -$10.5M |
|
|
SCHW
1697
CALL
Charles Schwab
SCHW
$187B
| $4.15M | 0.01% |
+100,000
| New | +$4.52M |
|
1698
argenx
ARGX
$66.3B
| $4.15M | 0.01% |
43,213
-62,231
| -59% | -$5.53M |
|
1699
A10 Networks
ATEN
$1.96B
| $4.15M | 0.01% |
664,448
+396,884
| +148% | +$2.4M |
|
1700
Kearny Financial
KRNY
$651M
| $4.14M | 0.01% |
323,227
-150,942
| -32% | -$1.96M |
|
Similar funds
Israel Englander's Q4 2018 Portfolio in Review
As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander withdrew a net $2.35B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.
- Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Israel Englander opened 702 new positions and closed 844 in Q4 2018.
- Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.